Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 16/20 | 0.59 |
| ▸ | TAS1R1 | Q7RTX1 | 15/20 | 0.59 |
| ▸ | TAS1R2 | Q8TE23 | 15/20 | 0.59 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4309782 | 0.81 | TAS1R3 (0.66) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL4159220 | 0.81 | TAS1R3 (0.66) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL4162795 | 0.81 | TAS1R3 (0.66) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL31290293 | 0.77 | TAS1R3 (0.73) | TAS1R3TAS1R1TAS1R2HTT | |
| SCHEMBL701897 | 0.74 | TAS1R3 (1.00) | TAS1R3TAS1R1TAS1R2ALDH1A1L3MBTL1 | |
| SCHEMBL702098 | 0.73 | TAS1R3 (0.78) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL4159172 | 0.73 | TAS1R3 (0.79) | TAS1R3TAS1R1TAS1R2HTTALDH1A1 | |
| SCHEMBL4170527 | 0.73 | TAS1R3 (0.62) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL4170336 | 0.72 | TAS1R3 (0.67) | TAS1R3TAS1R1TAS1R2HTT | |
| SCHEMBL13927784 | 0.72 | TAS1R3 (0.80) | TAS1R3TAS1R1TAS1R2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | DEWIS MARK L | 2009-02-19 | — | — | US | disclosed |
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | DEWIS MARK L | 2009-02-19 | — | — | US | disclosed |
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | DEWIS MARK L | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | TAS2R10, TAS2R50, TAS2R8 | TAS1R3 27/4885TAS1R1 23/4885TAS1R2 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.